Menu
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
NEW YORK, Aug. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially misleading business information to the investing public.
NEW YORK, Aug. 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially…
https://www.investing.com/news/pro/outset-medical-inc-receives-investment-bank-analyst-rating-update-3156489
The following slide deck was published by Outset Medical, Inc.
Outset Medical halts TabloCart shipments after receiving FDA warning letter apark Mon, 08/07/2023 - 10:04
LOS ANGELES, CA / ACCESSWIRE / August 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, proclaims that it’s investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or “the Company”) (NASDAQ: OM) for violations of the securities laws. The investigation focuses on whether the Company issued false […] The post INVESTOR ACTION NOTICE: The Schall Law Firm Proclaims it’s Investigating Claims Against Outset Medical, Inc. and Encourages Investors with Losses to Contact the Firm appeared first on TodaysStocks.com .
NEW YORK, Aug. 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially misleading business information to the investing public.
In its Q2 earnings release, Outset Medical Inc (NASDAQ: OM ) announced it has paused the shipment of TabloCart with Prefiltration, an accessory for the Tablo System, pending the FDA''s clearance of a 510(k) the company plans to submit later this month . "Since receiving the Warning Letter on July 6, we have made the decision to file a 510(k) for TabloCart with Prefiltration and pause distribution of the product until a 510(k) clearance … Full story available on Benzinga.com
Outset Medical, Inc. (NASDAQ:NASDAQ:OM) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ETCompany ParticipantsJim Mazzola - Vice President, Investor RelationsLeslie Trigg - Chair…
Outset Medical (NASDAQ: OM ) is set to give its latest quarterly earnings report on Wednesday, 2023-08-02. Here''s what investors need to know before the announcement. Analysts estimate that Outset Medical will report an earnings per share (EPS) of $-0.73. Outset Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com